Amritanshu B Joshi
Overview
Explore the profile of Amritanshu B Joshi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dey R, Joshi A, Oliveira F, Pereira L, Guimaraes-Costa A, Serafim T, et al.
Cell Host Microbe
. 2018 Jan;
23(1):134-143.e6.
PMID: 29290574
Leishmania donovani parasites are the cause of visceral leishmaniasis and are transmitted by bites from phlebotomine sand flies. A prominent feature of vector-transmitted Leishmania is the persistence of neutrophils at...
2.
Banerjee A, Bhattacharya P, Dagur P, Karmakar S, Ismail N, Joshi A, et al.
J Immunol
. 2017 Dec;
200(1):163-176.
PMID: 29187586
No vaccine exists against visceral leishmaniasis. To develop effective vaccines, we have previously reported protective role of live attenuated centrin gene-deleted ( ) parasites through induction of Th1 type immune...
3.
Bhattacharya P, Dey R, Dagur P, Joshi A, Ismail N, Gannavaram S, et al.
PLoS Negl Trop Dis
. 2016 Sep;
10(8):e0004963.
PMID: 27580076
Background: Visceral leishmaniasis (VL) caused by the protozoan parasite Leishmania donovani causes severe disease. Age appears to be critical in determining the clinical outcome of VL and at present there...
4.
Banerjee A, Bhattacharya P, Joshi A, Ismail N, Dey R, Nakhasi H
Cell Immunol
. 2016 Jul;
309:37-41.
PMID: 27444130
The clinical outcome of Leishmania pathogenesis ranges from active skin lesions to fatal visceral dissemination and severely impaired T cell immunity. It is well established that a strong Th1 immune...
5.
Maurya R, Bhattacharya P, Ismail N, Dagur P, Joshi A, Razdan K, et al.
Am J Trop Med Hyg
. 2016 Apr;
95(1):109-119.
PMID: 27114296
Visceral leishmaniasis (VL) is caused by the protozoan parasite Leishmania donovani There are no vaccines and available drugs against leishmaniasis are toxic. Immunomodulators that specifically boost the anti-microbial activities of...
6.
Bhattacharya P, Dey R, Dagur P, Kruhlak M, Ismail N, Debrabant A, et al.
Infect Immun
. 2015 Jul;
83(10):3800-15.
PMID: 26169275
Visceral leishmaniasis (VL) causes significant mortality and there is no effective vaccine. Previously, we have shown that genetically modified Leishmania donovani parasites, here described as live attenuated parasites, induce a...